Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006-2008

被引：71
|
作者：
Pettus, Liping H. [1 ]
Wurz, Ryan P. [1 ]
机构：
[1] Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2008年 / 8卷 / 16期
关键词：
D O I：
10.2174/156802608786264245
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation. It has been the subject of extensive efforts in both basic research and drug discovery for the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, where aberrant cytokine signaling is the driver of the disease. This article reviews the patent and journal publication activities during 2006-2008 describing novel small molecule p38 alpha inhibitors.
引用
收藏
页码：1452 / 1467
页数：16
相关论文
共 50 条
  • [1] New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase
    Peifer, C
    Wagner, G
    Laufer, S
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (02) : 113 - 149
  • [2] Novel inhibitors of p38 MAP kinase.
    Shetty, R
    Moffett, KK
    Nguyen, D
    Kelly, MJ
    Michelotti, EL
    Dorsey, BD
    Springman, E
    Bukhtiyarova, M
    Northrop, K
    Chai, XM
    Saporito, MS
    Ochman, AR
    Karpusas, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
  • [3] P38 MAP kinase inhibitors for the treatment of arthritis
    Barlocco, D
    Langston, S
    DRUG DISCOVERY TODAY, 2001, 6 (15) : 808 - 809
  • [4] p38 MAP Kinase Inhibitors as Anti inflammatory Agents
    Amir, Mohammad
    Somakala, K.
    Ali, Sazid
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (14) : 2082 - 2096
  • [5] The journey of p38 MAP kinase inhibitors: From bench to bedside in treating inflammatory diseases
    Yang, Fuwei
    Zhao, Li-Jie
    Xu, Qinli
    Zhao, Jianhui
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280
  • [6] Novel p38α MAP kinase inhibitors identified from yoctoReactor DNA-encoded small molecule library
    Petersen, L. K.
    Blakskjaer, P.
    Chaikuad, A.
    Christensen, A. B.
    Dietvorst, J.
    Holmkvist, J.
    Knapp, S.
    Korinek, M.
    Larsen, L. K.
    Pedersen, A. E.
    Roehm, S.
    Slok, F. A.
    Hansen, N. J. V.
    MEDCHEMCOMM, 2016, 7 (07) : 1332 - 1339
  • [7] A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis
    Brown, DS
    Belfield, AJ
    Brown, GR
    Campbell, D
    Foubister, A
    Masters, DJ
    Pike, KG
    Snelson, WL
    Wells, SL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5383 - 5387
  • [8] The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
    Yong, Hae-Young
    Koh, Min-Soo
    Moon, Aree
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (12) : 1893 - 1905
  • [9] Recent Developments of p38α MAP Kinase Inhibitors as Anti-inflammatory Agents Based on the Imidazole Scaffolds
    Kong, Ting-Ting
    Zhang, Cheng-Mei
    Liu, Zhao-Peng
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (15) : 1997 - 2016
  • [10] Identification of Potential Small Molecule Binding Pockets in p38α MAP Kinase
    Gomez-Gutierrez, Patricia
    Rubio-Martinez, Jaime
    Perez, Juan J.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (10) : 2566 - 2574
12345